The Pharmaceutical Regulatory Affairs in China 2026 is a course dedicated to the key areas of pharmaceutical regulatory affairs in China, Hong Kong, Macau and Taiwan.
Key Topics
An overview of import and local manufacture registration
Drug regulatory systems
An interpretation of practical aspects
Clinical product development including CMC regulatory requirements
The opportunity to exchange experiences with other delegates
